Borje S Andersson

11PUBLICATIONS
94CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 23, 2026
A multi-center clinical trial of allogeneic hematopoietic stem cell transplantation in transfusion-dependent thalassemia.

Rongrong Liu, Hongwen Xiao, Chunjie Qin

|Aug 25, 2025
High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Yago Nieto, John F Ward, Wayne Hofstetter

|Jan 13, 2025
Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.

Yago Nieto, Jeremy Ramdial, Benigno Valdez

|Sep 28, 2024
High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas.

Jeremy Ramdial, Ruitao Lin, Peter F Thall

|Mar 15, 2024
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.

Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand

|Dec 19, 2023
Autologous engineered T cell receptor therapy in advanced cancer.

Apostolia M Tsimberidou, Mehmet A Baysal, Abhijit Chakraborty

Pageof 2

Frequent Collaborators

5 joint publications

Jeremy Ramdial

4 joint publications

Uday R Popat

4 joint publications

Elizabeth J Shpall

3 joint publications

Roland Bassett